Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 1191 composition records across product categories including Food and drug, Personal care, Cleaning products and household care.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of POLYOXYL 40 HYDROGENATED CASTOR OIL in our catalog (epa_cpdat).
Products
1,191
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 1191 composition records across product categories including Food and drug, Personal care, Cleaning products and household care. EPA CPDat classifies this chemical for functional uses including Surfactant (surface active agent), Emulsifier, Softener and conditioner.
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 20 %w/v
US
FDA
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Route: TOPICAL; Dosage form: CREAM; Potency: 1.9 %w/w
US
FDA
Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 352 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 3 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 0.53 %w/v
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 3319 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED; Potency: 101.25 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 3240 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 120 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 50 mg
US
FDA
FDA NDC lists this ingredient in 5 drug products and 5 package presentations.
US
FDA
openFDA substance registry classifies this ingredient as structurallydiverse.